CN106479924A - The preparation of a kind of Clostridium butyricum and clostridium butyricum active bacteria preparation and application - Google Patents
The preparation of a kind of Clostridium butyricum and clostridium butyricum active bacteria preparation and application Download PDFInfo
- Publication number
- CN106479924A CN106479924A CN201610927003.9A CN201610927003A CN106479924A CN 106479924 A CN106479924 A CN 106479924A CN 201610927003 A CN201610927003 A CN 201610927003A CN 106479924 A CN106479924 A CN 106479924A
- Authority
- CN
- China
- Prior art keywords
- clostridium butyricum
- preparation
- culture
- lxkj
- active bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000193171 Clostridium butyricum Species 0.000 title claims abstract description 167
- 241000894006 Bacteria Species 0.000 title claims abstract description 68
- 238000002360 preparation method Methods 0.000 title claims abstract description 44
- 206010012735 Diarrhoea Diseases 0.000 claims abstract description 20
- 241000588724 Escherichia coli Species 0.000 claims abstract description 20
- 239000002609 medium Substances 0.000 claims abstract description 20
- 239000001963 growth medium Substances 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 238000009472 formulation Methods 0.000 claims abstract description 10
- 244000144977 poultry Species 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 31
- 241000287828 Gallus gallus Species 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 21
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 20
- 238000000855 fermentation Methods 0.000 claims description 19
- 230000004151 fermentation Effects 0.000 claims description 19
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 15
- 239000008103 glucose Substances 0.000 claims description 15
- 210000004534 cecum Anatomy 0.000 claims description 14
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 12
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 11
- 244000005700 microbiome Species 0.000 claims description 11
- 239000000661 sodium alginate Substances 0.000 claims description 11
- 235000010413 sodium alginate Nutrition 0.000 claims description 11
- 229940005550 sodium alginate Drugs 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 10
- 239000004201 L-cysteine Substances 0.000 claims description 9
- 235000013878 L-cysteine Nutrition 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 8
- 239000004310 lactic acid Substances 0.000 claims description 8
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 7
- 241000252983 Caecum Species 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- 239000000725 suspension Substances 0.000 claims description 7
- 239000001888 Peptone Substances 0.000 claims description 6
- 108010080698 Peptones Proteins 0.000 claims description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- 229940041514 candida albicans extract Drugs 0.000 claims description 6
- 239000004202 carbamide Substances 0.000 claims description 6
- 235000013877 carbamide Nutrition 0.000 claims description 6
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 235000019319 peptone Nutrition 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- GNBVPFITFYNRCN-UHFFFAOYSA-M sodium thioglycolate Chemical compound [Na+].[O-]C(=O)CS GNBVPFITFYNRCN-UHFFFAOYSA-M 0.000 claims description 6
- 229940046307 sodium thioglycolate Drugs 0.000 claims description 6
- 239000012137 tryptone Substances 0.000 claims description 6
- 239000012138 yeast extract Substances 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 230000009467 reduction Effects 0.000 claims description 5
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 3
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 229910021536 Zeolite Inorganic materials 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 3
- 230000003321 amplification Effects 0.000 claims description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 3
- 235000009973 maize Nutrition 0.000 claims description 3
- 235000012054 meals Nutrition 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 239000004575 stone Substances 0.000 claims description 3
- 239000010457 zeolite Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 244000283207 Indigofera tinctoria Species 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 244000173166 Pyrus ussuriensis Species 0.000 claims description 2
- 235000011572 Pyrus ussuriensis Nutrition 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims description 2
- 230000008014 freezing Effects 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 239000002504 physiological saline solution Substances 0.000 claims description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Inorganic materials [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 230000004899 motility Effects 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 abstract description 30
- 230000001580 bacterial effect Effects 0.000 abstract description 23
- 230000000968 intestinal effect Effects 0.000 abstract description 15
- 241000193468 Clostridium perfringens Species 0.000 abstract description 13
- 241000607142 Salmonella Species 0.000 abstract description 13
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 241000186779 Listeria monocytogenes Species 0.000 abstract description 8
- 108010000912 Egg Proteins Proteins 0.000 abstract description 7
- 102000002322 Egg Proteins Human genes 0.000 abstract description 7
- 210000003278 egg shell Anatomy 0.000 abstract description 7
- 241000607768 Shigella Species 0.000 abstract description 6
- 230000000813 microbial effect Effects 0.000 abstract description 6
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 abstract description 5
- 241000193830 Bacillus <bacterium> Species 0.000 abstract description 5
- 241001465754 Metazoa Species 0.000 abstract description 5
- 235000009392 Vitis Nutrition 0.000 abstract description 5
- 241000219095 Vitis Species 0.000 abstract description 5
- 244000037640 animal pathogen Species 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 3
- 238000011218 seed culture Methods 0.000 abstract description 3
- 206010010774 Constipation Diseases 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 26
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 17
- 241000282898 Sus scrofa Species 0.000 description 16
- 230000000694 effects Effects 0.000 description 7
- 230000000877 morphologic effect Effects 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 5
- 235000014590 basal diet Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000012533 medium component Substances 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 108020004465 16S ribosomal RNA Proteins 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 235000021050 feed intake Nutrition 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 241000305071 Enterobacterales Species 0.000 description 3
- 241000192125 Firmicutes Species 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 241001052560 Thallis Species 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 238000013401 experimental design Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 241000607762 Shigella flexneri Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000013316 zoning Methods 0.000 description 2
- IFBHRQDFSNCLOZ-IIRVCBMXSA-N 4-nitrophenyl-α-d-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-IIRVCBMXSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102100027887 Deaminated glutathione amidase Human genes 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 101000632167 Homo sapiens Deaminated glutathione amidase Proteins 0.000 description 1
- 101000996087 Homo sapiens Omega-amidase NIT2 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 101000996085 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) Nitrogen catabolic enzyme regulatory protein Proteins 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 102100034446 Omega-amidase NIT2 Human genes 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 208000035199 Tetraploidy Diseases 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- ONTQJDKFANPPKK-UHFFFAOYSA-L chembl3185981 Chemical compound [Na+].[Na+].CC1=CC(C)=C(S([O-])(=O)=O)C=C1N=NC1=CC(S([O-])(=O)=O)=C(C=CC=C2)C2=C1O ONTQJDKFANPPKK-UHFFFAOYSA-L 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000006160 differential media Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000036750 egg laying performance Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 238000013081 phylogenetic analysis Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940115939 shigella sonnei Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/145—Clostridium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Abstract
The invention discloses the preparation of a kind of Clostridium butyricum and clostridium butyricum active bacteria preparation and application, Clostridium butyricum (Clostridium butyricum) LXKJ on March 24th, 1,2016 is preserved in China typical culture collection center, preserving number is CCTCC NO:M201613.Also disclosed the production method of seed culture medium, fermentative medium formula, condition of culture and its active bacteria formulation of this bacterial strain simultaneously.The Clostridium butyricum that the present invention provides is acidproof, alkaline-resisting, high temperature resistant, produce butanoic acid ability strong, all inhibited to animal pathogens such as escherichia coli, Salmonella, shigella, golden yellow Fructus Vitis viniferae bacillus, Listeria monocytogenes, bacillus perfringens, the diarrhoea that poultry can be prevented to be caused by escherichia coli, Salmonella, bacillus perfringens etc., improves intestinal microbial population balance, promotes growth of animals or poultry, alleviate prevention of sow constipation, improve laying hen egg size, improve laying hen eggshell quality, reduce feedstuff-egg ratio.
Description
Technical field
The invention belongs to field of microbial fermentation, be related to a kind of Clostridium butyricum and clostridium butyricum active bacteria preparation production method and
Application.
Background technology
Cultivate the expansion further of scale now with people, in order to improve culture benefit, various antibiotic are as growth-promoting
The a large amount of use of long agent has become as a kind of universal phenomenon, and its drawback increasingly highlights, such as drug residue, the report of pathogenic bacteria of drug-resistant
Road, unbalance, environmental pollution of microbial population of animal intestinal tract etc., have seriously threatened health and the food safety of the mankind.Microbial ecological agent
As antibiotic substitute products that are a kind of safe efficient, pollution-free and having no drug resistance progressively as diseases prevention, growth promotion formulation application
In aquaculture.
Microbial ecological agent is probiotics fermention and the biological system of microbial cells obtained from rear processing and its metabolite
Agent and active bacteria formulation.Therefore there is maintenance intestinal microecology balance, improve word material transformation efficiency, improve growth of animals or poultry performance, carry
High immunologic function, antioxidation and anti-cancer and improve environment, reduce the effect such as generation of harmful substance, are increasingly subject to aquaculture and are chased after
Hold in both hands.
Clostridium butyricum (Clostridium butyricum), it is to enter closely to control doctor by Chiba, Japan medical university palace first
Find first and report, therefore Clostridium butyricum is also designated as Clostridium Butyricum, Japan also becomes research Clostridium butyricum history simultaneously
Country the longest.Clostridium butyricum (Clostridium butyricum) it is gram positive bacteria, thalline is in straight or bending,
(0.5 ~ 1.7x2.4 ~ 7.6 μm), single or paired, short chain, amphitrichous are movable, and thalline can form spore, and middle part enlarges into
Fusiformis, spore bias Cheng Ciduan life, no epispore or appendage；How rounded bacterium colony is, less, raised, milky, butanoic acid shuttle
Pseudomonas, in anaerobe, can produce butanoic acid, propanoic acid, acetic acid, can also produce hydrogen etc. simultaneously, studies have found that during liquid fermentation
, to the such as bacillus bifiduss of the probiotic bacteria in the animal intestinals such as pig, chicken, the growth of lactic acid bacteria etc. is numerous for the butanoic acid of Clostridium butyricum generation, acetic acid
Grow and there is good facilitation, and harmful intestinal tract bacteria such as escherichia coli, bacillus perfringens, salmonella typhi etc. are all had
There is good inhibiting effect, the butanoic acid that metabolism produces directly is utilized by intestinal fine hair, promotes gut epithelium histiocytic
Regeneration and reparation, the hydrogen that metabolism produces has repair to the oxidative damage of body liver, kidney organ, can strengthen machine simultaneously
Body function of detoxification.Therefore Clostridium butyricum is known as " intestinal health first bacterium ".
Patent CN201110116927, CN201110126498 etc. has been related to the production and processing method of Clostridium butyricum, but
These method generally existing medium components are complicated, and fermentation costs are high, are not suitable for industrialized production problem.
CN201110454790, CN201310082656, CN201310083900, CN201410469885 etc. have been related to butanoic acid shuttle
The application of bacterium, but be not directed to various dose Clostridium butyricum to pig, laying hen, meat chicken production performance impact.
Content of the invention
The present invention from health pig intestinal separation screening one plant of Clostridium butyricum (Clostridium butyricum)LXKJ-
1, its activity is high, strong stress resistance, have found its growth suitable, the culture medium of breeding and condition of culture, fermentation gained culture simultaneously
Thing viable count is high, spore rate is high, and the medium component that this invention is used is simple, with low cost, is well suited for the scale of factory
Produce.Clostridium butyricum (Clostridium butyricum) LXKJ-1 is acidproof, alkaline-resisting, high temperature resistant, produces butanoic acid ability strong, to big
The animal pathogens such as enterobacteria, Salmonella, shigella, golden yellow Fructus Vitis viniferae bacillus, Listeria monocytogenes, bacillus perfringens
Diarrhoea all inhibited, that pig, chicken can be prevented to be caused by escherichia coli, Salmonella, bacillus perfringens etc., improves intestinal
Road colony balance, promotes pig, chicken growth, improves laying rate of laying hen and egg size, improve eggshell quality, reduce feedstuff-egg ratio.
The technical scheme is that：
A kind of Clostridium butyricum, entitled LXKJ-1, specific name is：Clostridium butyricum LXKJ-1Clostridium butyricumLXKJ-1, deposit number is：CCTCC NO:M201613, preservation date：On March 24th, 2016, preservation address
For：China, Wuhan, Wuhan University, depositary institution：China typical culture collection center.
A kind of clostridium butyricum active bacteria preparation of Clostridium butyricum LXKJ-1 preparation.
A kind of clostridium butyricum active bacteria formulation preparation method, comprises the following steps：
1. by Clostridium butyricum (Clostridium butyricum) LXKJ-1 its be deposited in glycerol tube, freezing, by draw
Collimation method accesses slant medium, under anaerobic, 35～37 DEG C of culture 20～24h, wash lower spore with physiological saline solution and hang
Liquid, as original bacterium solution；
2. original bacterium solution is carried out amplification cultivation for strain, it comprises the following steps that：
The bacteria suspension of 1 volume is linked in the primary-seed medium of 20 volumes, in 1 L indigo plant lid reagent bottle, anaerobic condition
Under, 35～37 DEG C culture 8～12 h, as primary seed solution；
The primary seed solution of 1 volume is linked in the secondary seed medium of 10 volumes, in 20 L fermentation tanks, nitrogen environment
Under, 35～37 DEG C culture 8～12 h, as secondary seed solution；
Secondary seed solution is moved in the three grade fermemtation culture medium of 20 times of volumes, in 200 L fermentation tanks, under nitrogen environment, 35
～37 DEG C culture 20～24 h, that is, obtain Clostridium butyricum (Clostridium butyricum) LXKJ-1 culture；
3. microorganism collection is carried out to culture using supercentrifugal process, the bacterium mud being collected by centrifugation；
4. press 1:1～5 defatted milk powder suspension of ratio interpolation 5～20%, sucrose, Lactose, trehalose, maltodextrin, Pyrusussuriensiss
One of alcohol, glycerol or more than one combination, as freeze drying protectant, prepare lyophilizing thalline using freeze-drying；
5. using one of glucose, starch, stone powder, zeolite powder, bean cake powder, maize cob meal, wheatfeed or more than one
Combination is diluted to mycopowder as adjuvant, as needed, is configured to the clostridium butyricum active bacteria preparation of different viable counts.
Further, above-mentioned slant medium is：Glucose 1.2%, L-Cysteine 0.03%, sodium thioglycolate
0.03%, K2HPO40.2%, yeast extract 0.3%, soy peptone 0.5%, peptone 1%, tryptone 1%, NaCl
0.3%, sodium alginate 0.5%, agar 2%, pH 6.5～7.0.
Further, above-mentioned primary-seed medium is：Glucose 5～30 g/L, L-Cysteine 0.1～5 g/L,
Sodium thioglycolate 0.1～5 g/L, K2HPO40.1～5 g/L, yeast extract 1～10 g/L, soy peptone 5～20
G/L, NaCl 1～10 g/L, sodium alginate 1～10 g/L, pH 6.5～7.0；
Described secondary seed medium is：Peptone 10～40 g/L, soybean cake powder 1～5 g/L, glucose 10～30 g/L,
KNO30.5～2.0 g/L, K2HPO40.5～2.0 g/L, MgSO40.1～0.5 g/L, MnSO40.1～0.5 g/L, L-
Cysteine 0.1～1.0 g/L, sodium alginate 1.0～10 g/L, carbamide 1.0～5.0 g/L, CaCO31.0～10 g/
L, pH 6.5～7.0；
Described three grade fermemtation culture medium is：Semen Maydis powder 10～40 g/L, soybean cake powder 1～5 g/L, tryptone 10～40 g/L,
Glucose 10～40 g/L, NH4NO30.5～2.0 g/L, K2HPO4.5～2.0 g/L, MgSO40.1～0.5 g/L,
MnSO40.1～0.5 g/L, L-Cysteine 0.1～1.0 g/L, sodium alginate 1.0～10 g/L, carbamide 1.0～5.0
G/L, CaCO31.0～10 g/L, pH6.5～7.0；
Above all of culture medium is required for steam sterilization before use（121 DEG C, 30 min）, cool down stand-by.
A kind of above-mentioned Clostridium butyricum or above-mentioned Clostridium butyricum preparation answering in preparing animal and fowl fodder microbe additive
With.
Further, above-mentioned acid clostridium active bacteria formulation is used for ablactational baby pig and improves production performance and reduction diarrhea rate, and shows
Write and reduce escherichia coli and Salmonella quantity in caecum.
Further, above-mentioned clostridium butyricum active bacteria preparation is used for laying hen and improves production performance, Egg Quality, increases broiler caecum
The quantity of middle lactic acid bacteria and bacillus bifiduss and reduction escherichia coli quantity.
Further, above-mentioned clostridium butyricum active bacteria preparation is used for broiler and improves broiler survival rate, reduces diarrhea rate, promotes life
Long, increase the quantity of lactic acid bacteria and bacillus bifiduss and reduction escherichia coli quantity in broiler caecum.
The present invention from health pig intestinal separation screening one plant of Clostridium butyricum (Clostridium butyricum)LXKJ-
1, its activity is high, strong stress resistance, have found its growth suitable, the culture medium of breeding and condition of culture, fermentation gained culture simultaneously
Thing viable count is high, spore rate is high, and the medium component that this invention is used is simple, with low cost, is well suited for the scale of factory
Produce.Clostridium butyricum (Clostridium butyricum) LXKJ-1 is acidproof, alkaline-resisting, high temperature resistant, produces butanoic acid ability strong, to big
The animal pathogens such as enterobacteria, Salmonella, shigella, golden yellow Fructus Vitis viniferae bacillus, Listeria monocytogenes, bacillus perfringens
Diarrhoea all inhibited, that pig, chicken can be prevented to be caused by escherichia coli, Salmonella, bacillus perfringens etc., improves intestinal
Road colony balance, promotes pig, chicken growth, improves laying rate of laying hen and egg size, improve eggshell quality, reduce feedstuff-egg ratio.
The Clostridium butyricum that the present invention provides has acidproof, alkaline-resisting, resistant to elevated temperatures feature.PH value 1.0-4.0 remains to survive, pH
All can grow during value 5.0-12.0, optimum pH is 6.0-7.0；External 80 DEG C of dry heat treatment 10min, 90 DEG C of dry heat treatment
10min, 100 DEG C of dry heat treatment 5min spore survival rates 100%.
It is strong, to escherichia coli, Salmonella, shigella, golden yellow that the Clostridium butyricum that the present invention provides produces butanoic acid ability
The animal pathogens such as Fructus Vitis viniferae bacillus, Listeria monocytogenes, bacillus perfringens are all inhibited.
Brief description
Fig. 1 Clostridium butyricum (Clostridium butyricum) LXKJ-1 culture bacterium colony photo（This bacterial strain bacterium colony is in
Circle, milky, bacterium colony projection）；
Fig. 2 Clostridium butyricum (Clostridium butyricum) LXKJ-1 spore photo (spore ovalize, spore wall
Thick)；
Fig. 3 Clostridium butyricum (Clostridium butyricum) taxonomy of LXKJ-1 and phylogenetic tree；
The bacteriostasis comparison diagram to bacillus perfringens for Fig. 4 Clostridium butyricum centrifuged supernatant；
Clostridium butyricum in accompanying drawing 1 is numbered and is：LXKJ-1, specific name is：Clostridium butyricum LXKJ-1Clostridium butyricumLXKJ-1, deposit number is：CCTCC NO:M201613, preservation date：On March 24th, 2016, preservation address
For：China, Wuhan, Wuhan University, depositary institution：China typical culture collection center.
Specific embodiment
To be further elucidated with the present invention below by the detailed description of specific embodiment, but to be not the limit to the present invention
System, only illustrates.
Embodiment one Clostridium butyricum (Clostridium butyricum) LXKJ-1 separation and identification
Clostridium butyricum (Clostridium butyricum) LXKJ-1 is located away from the intestinal of health pig, first will collection sample
In 80 DEG C of heating in water bath 10 min after product normal saline dilution, to kill non-sporeformer；Then it is inoculated in slant medium
On, cultivate 24-30 h in 36 DEG C of anaerobic jars, Preliminary Identification is carried out to bacterial strain by colonial morphology and thalli morphology, therefrom selects
Go out cultural characteristic, colonial morphology and thalli morphology and meet the bacterial strain of Clostridium butyricum feature continuously to rule purification culture three generations, respectively
Marker number enters next step identification and screens.
Further determine that Clostridium butyricum (Clostridium butyricum) LXKJ-1 taxonomy, the present invention adopts
This bacterial strain is classified identify with conventional sorting methods and molecular classification method.
1 morphologic observation culture medium
Glucose 1.2%, L-Cysteine 0.03%, sodium thioglycolate 0.03%, K2HPO40.2%, yeast extract 0.3%,
Soy peptone 0.5%, peptone 1%, tryptone 1%, NaCl 0.3%, sodium alginate 0.5%, agar 2%, pH 6.5
～7.0
2 primers
Using bacterial universal primers, primer is synthesized by AudioCodes biotechnology (Wuhan) company limited.Its sequence is respectively： 27F
(5 '-AGAGTTTGATCCTGGCTC-3 ') and 1492R (5 '-CGGCTACCTTGTTACGACTT-3 ')
3 test methods
3.1 morphological observation
The microbionation culture of pure culture will be determined, observe its morphological characteristic
Flat board four zoning collimation method, obtains single bacterium colony, observe the size of its bacterium colony, color, shape, color and luster, transparency, consistency and
The features such as edge, and record.
Bacterial cell form（Individual morphology）Observation
Bacterial strain to be checked is carried out with Gram’s staining, in gram positive bacteria body, contains special nucleoprotein magnesium salt and polysaccharide
Complex, can be combined very firm with the complex of iodine and crystal violet, be difficult decolour, negative bacterium complex combination degree bottom, inhale
Attached dye is poor, easily decolours.Observe its Gram’s staining situation under an optical microscope, judge that it is gram positive bacteria or leather
Lan Shi negative bacterium.And the morphological characteristic of preliminary observation cell.
3.2 Clostridium butyricum (Clostridium butyricum) LXKJ-1 physiological and biochemical property
3.2.1 API 20NE identification mark
3.2.1.1 the preparation of test bar
Take out culture box, strain number and dat recorder in side, add in culture plate sterilized water cover honeycomb little recessed in, prevent
Only in incubation, reagent strip is dried.Take out test bar from the package, be placed in culture plate.
3.2.1.2 the preparation of inoculum
Obtain the flat board of inoculation experiments bacterial strain with four zoning collimation methods, scraped new fresh thalli to normal saline with aseptic cotton carrier, extremely
Maxwell concentration 0.5.
3.2.1.3 the inoculation of reagent strip
3.2.1.4 inoculate saline bacteria suspension respectively from NO with same suction pipe3To PNPG developmental tube.Test strips slightly forward
Incline and the top of suction pipe is leaned against tubule inner edge liquid feeding body, to avoid the formation of bubble.
3.2.1.5 open an ampoule bottle APIAUX culture medium and add 200 microlitres of remaining normal saline bacteria suspensions to ampoule
Bottle, carefully mixes, it is to avoid have bubble to produce.Fill it up with GUL to PAC pipe, 3 line experiment GLU, ADH, URE, covered with mineral oil
Lid, cultivates in 29 DEG C.
3.2.2 NO3Measure：
Plus a NIT1 and NIT2 to NO3Pipe, after 5min, red expression is positive, because nitrogen may produce feminine gender, plus 2-3mgZn
To NO3Pipe, keeps after 5min not changing color as the positive, reddens as feminine gender.
Table 1 bacterial strain LXKJ-1 physio-biochemical characteristics enzyme activity, carbon assimilation
+：Positive reaction； -：Negative reaction； W：Weakly positive is reacted.
Table 2 bacterial strain LXKJ-1 physio-biochemical characteristics utilize carbon source to produce acid
+：Positive reaction； -：Negative reaction
3.3 Clostridium butyricum (Clostridium butyricum) LXKJ-1 molecular biology identification
3.3.1 Clostridium butyricum (Clostridium butyricum) LXKJ-1 genomic DNA extraction adopt SDS-CTAB method.
3.3.2 Clostridium butyricum (Clostridium butyricum) amplification of LXKJ-116S rDNA gene used
Primer is 27F (5'AGAGTTTGATCCTGGCTCAG), 1492R (5'TACGGCTACCTTGTTACGACTT), and sequence measurement is adopted
Use clone sequencing.PCR reaction system is 50 μ L: ddH2O 40.7 μ L, 10 × Buffer 5 μ L, dNTP Mixture
（10 μM）1 μ L, primer 2 7F（10 μmol/L）1 μ L, primer 1492R（10 μmol/L）1 μ L,TaqArchaeal dna polymerase 0.3 μ
L, template DNA 1 μ L.PCR amplification condition is：94 DEG C of 5 min, 95 DEG C of 30 s, 56 DEG C of 30s, 72 DEG C of 90 s, follow
Ring number of times 30 times；72 ℃ 8 min.Examining order entrusts Shanghai bioengineering Services Co., Ltd to complete.
3.3.3 the comparison analysis of sequencing result
In EZ-Biocloud, BLAST comparison is carried out to the sequencing result of bacterial strain, chooses representative strain, using adjacent method（NJ）Method
Tetraploid rice is carried out to this bacterial strain, simultaneously constructing system cladogram, then determine this bacterial strain by Phylogenetic analysis
Race relation.In conjunction with the cultural characteristic of bacterial strain, morphological characteristic and the evolutionary relationship to this bacterial strain etc., preliminary classification is carried out to bacterial strain
Identification.
4 result of the tests
4.1 Clostridium butyricum (Clostridium butyricum) LXKJ-1 morphological observations
4.2 Clostridium butyricum (Clostridium butyricum) LXKJ-1 molecular biology identification result
4.2.1 Clostridium butyricum (Clostridium butyricum) LXKJ-1 16S rDNA sequencing results use
DNAMAN5.2 software splice, determine this fragment by 1412 base compositions, obtain Clostridium butyricum (Clostridium butyricum) LXKJ-1 16S rDNA sequence (seeing below table).
4.2.2 homology cladogram builds
Clostridium butyricum (Clostridium butyricum) the 16S rDNA the sequencing results of LXKJ-1 show, bacterial strain butanoic acid
Clostridium (Clostridium butyricum) LXKJ-1 and bacterial strainClostridium butyricumDSM 10702 (T) phase
It is 99.15% like degree to the maximum, next to thatClostridium diolisDSM 5431(T)（97.37%）WithClostridium saccharoperbutylacetonicumN1-4(HMT)(T)（97.23%）, then build bacterium with MEGA 5.05 software NJ method
Strain Clostridium butyricum (Clostridium butyricum) LXKJ-1 phyletic evolution growth tree, tied according to 16S rDNA comparison result
Close morphological characteristic of bacterial strain etc. and determine that this bacterial strain is potential Clostridium butyricum new species（See accompanying drawing 3）.
Embodiment two Clostridium butyricum three grade fermemtation（200L fermentation tank）
（1）The preparation of primary seed solution：By the Clostridium butyricum preparing (Clostridium butyricum) LXKJ-1 is original
Bacterium solution is inoculated on primary-seed medium and carries out seed preparation, and first order seed, using blue lid bottle preparation, prepares volume 1L, culture
Base is as follows：Glucose 15 g/L, L-Cysteine 1 g/L, sodium thioglycolate 1 g/L, K2HPO42 g/L, yeast extract
5 g/L, soy peptone 20 g/L, NaCl 5 g/L, 36 DEG C of sodium alginate 5 g/L, pH 6.5～7.0 cultivation temperature, training
Foster time 24h.
（2）The preparation of secondary seed solution：By ready one-level Clostridium butyricum (Clostridium butyricum)
LXKJ-1 seed liquor is inoculated in 20L fermentation tank according to 5% inoculum concentration, and as secondary seed solution, secondary seed formula of liquid is two grades
Seed culture medium, concrete culture medium prescription is as follows：Peptone 20 g/L, soybean cake powder 2.5 g/L, glucose 15 g/L, NH4NO31
G/L, K2HPO41 g/L, MgSO40.1 g/L, MnSO40.1 g/L, L-Cysteine 0.5 g/L, sodium alginate 5 g/L,
Carbamide 5 g/L, CaCO31 g/L, pH 6.5～7.0,36 DEG C of cultivation temperature, incubation time 8h.
（3）Three grade fermemtation：By ready two grades of Clostridium butyricum (Clostridium butyricum) LXKJ-1 seed
Liquid is inoculated in 200L fermentation tank according to 10% inoculum concentration, is cultivated, and fermentation medium adopts fermentation medium, concrete culture
Based component is as follows：Semen Maydis powder 25 g/L, bean cake powder 15 g/L, tryptone 20 g/L, glucose 15 g/L, NH4NO31 g/L,
K2HPO41 g/L, MgSO40.1 g/L, MnSO40.1 g/L, CaCO31 g/L, L-Cysteine 0.5 g/L, alginic acid
Sodium 5 g/L, carbamide 5 g/L, pH 6.5～7.0,36 DEG C of cultivation temperature, incubation time 24h.
By the zymotic fluid viable count of above-mentioned three grade fermemtation gained up to 2.8*109More than cfu/mL, spore rate 95% with
On.
Embodiment three Clostridium butyricum lyophilizing mycopowder and the preparation of active bacteria formulation
（1）Thalline is collected by centrifugation：By the Clostridium butyricum of above-mentioned gained (Clostridium butyricum) LXKJ-1 fermentation
Liquid is centrifuged using tube centrifuge, and centrifugal speed is 12000rpm, and charging rate is 200L/h.
（2）The lyophilizing of thalline：Above-mentioned centrifugation gained bacterium mud is compared 1 according to weight:3, add the defatted milk of 20% after sterilizing
Powder suspension and 10% trehalose, mix, carry out vacuum lyophilization, freeze-drying time 24h.
（3）Lyophilizing mycopowder：Pulverize after thalline lyophilizing, prepared lyophilizing mycopowder.Produce gained using said method after measured
Mycopowder viable bacteria viable count reaches as high as 1.0*1011More than cfu/g.
（4）The preparation of clostridium butyricum active bacteria preparation：By above-mentioned gained mycopowder adopt glucose, starch, stone powder, zeolite powder,
One of bean cake powder, maize cob meal or wheatfeed or more than one as diluent be prepared into viable count be not less than 2.0*
108The clostridium butyricum active bacteria preparation of cfu/g.
In sum, the invention provides one plant of Clostridium butyricum (Clostridium butyricum) LXKJ-1 and should
The seed culture medium of bacterial strain, fermentative medium formula, condition of culture and its and using three grade fermemtation method produce Clostridium butyricum live
The method of bacteria preparation, the medium component that the method is used is simple, and with low cost, high financial profit is well suited for the rule of factory
Modelling produces, and fermentation gained culture viable count, spore rate are high.Because spore is a kind of hypopuss, very steady during depositing
Fixed, and there is good thermostability, therefore stability is had by force using the clostridium butyricum active bacteria preparation that above method produces, resistance to
The advantage of storage.
Test that example IV Clostridium butyricum is high temperature resistant
Clostridium butyricum active bacteria preparation is individually placed to 80 DEG C of process 10min, 20min, 30min in baking oven, 90 DEG C of process
5min, 10min, 15min, 100 DEG C process 5min, 10min, 15min, and 105 DEG C process 5min, 10min, 15min, at each
Reason take 3 parallel, process terminate room temperature cooling after measure viable count respectively.Take the meansigma methodss of 3 parallel results as terminating most
Really, different temperatures, the different impact to Clostridium butyricum for the high-temperature process time are investigated.Using dilution, flat band method carries out viable count
Measure.The results are shown in Table 3.
Table 3 clostridium butyricum active bacteria heat-resistance test
Result above can be seen that Clostridium butyricum LXKJ-1 in vitro 80 DEG C process 10min, 90 DEG C process 10min, 100
DEG C process 5min spore survival rate still be 100%.Illustrate that the spore that this bacterial strain is formed has good thermostability, can be effective
Protect thalline not affected by feed granulating process high temperature, can use as feed additive.
Embodiment five Clostridium butyricum produces butanoic acid and acetic acid ability
Clostridium butyricum is carried out flat board culture, is inoculated in fermentation medium, cultivate 24h under 37 DEG C of anaerobic conditions, in centrifuging and taking
Clear liquid, measures butanoic acid and acetic acid content using gas chromatography.Testing conditions：1 μ L gas phase sample injection is furnished with FID hydrogen fire
Flame ion detector and HP-Innowax 19091 N-213 capillary column（30 m×0.32 mm ×0.5 um）Gas phase color
Spectrum（Agilent Technologist, 7890A GC System）, carrier gas is helium, and its flow velocity is 1.8 mL/min, split ratio
40:1, heating schedule：90 DEG C of maintenance 0.5 min, rise to 110 DEG C, then the speed with 5 DEG C/min with the speed of 10 DEG C/min
Degree is raised to 170 DEG C, finally with the speed of 20 DEG C/min to 210 DEG C.Injector and 275 DEG C of detector temperature.
Measurement result：Butanoic acid content is 8.12 g/L, and acetic acid content is 1.37 g/L.Show that Clostridium butyricum LXKJ-1 produces
Butanoic acid ability is stronger.
Embodiment six Clostridium butyricum extracorporeal bacteria inhibitor test
Clostridium butyricum active bacteria preparation is carried out flat board culture, is inoculated in fluid medium, under 37 DEG C of anaerobic conditions, cultivate 48h
With Salmonella, escherichia coli, shigella, staphylococcus aureuses, Listeria monocytogenes, bacillus perfringens as target
Bacterium, is measured the bacteriostatic activity of Clostridium butyricum LXKJ-1 fermentation liquid, the results are shown in Table 4 using cup-plate method.
Table 4 Clostridium butyricum bacteriostatic test effect
Result shows, Clostridium butyricum is to salmonella typhi YF, Salmonella enteritidis S (ATCC13076), Salmonella typhimurium
Bacterium zjc (ATCC14028), S. pullonum C79-13, shigella flexneri zjc, shigella flexneri 268, dysentery will
Hayes bacterium 269, Shigella sonnei Z, e. coli bl21, swine escherichia coli（Wild strain）, chicken colibacillosis（Wild mushroom
Strain）, staphylococcus aureuses JN, Listeria monocytogenes Lis, Listeria monocytogenes Lu and bacillus perfringens all have well
Bacteriostatic activity.
The impact to Production Performance of Weaning Pigs and diarrhea rate for embodiment seven Clostridium butyricum
1 test method
1.1 test material：Clostridium butyricum（Every g of formulation contains clostridium butyricum active bacteria >=2.0 × 108cfu/g）.
Experimental animal：35 ± 1 age in days Du × big × long three way cross piglet.
EXPERIMENTAL DESIGN：Test is using single-factor design.Choose the basically identical sodium selenite 364 of 35 ± 1 age in days body weight,
It is randomly divided into 5 groups, every group 4 repetitions, often repeat 18（Four are wherein had to repeat 19）.Control group fed basal diet, 4
Basal diet Clostridium butyricum addition is that 250g/t, 500 g/t, 1000 g/t, 2000 g/t Clostridium butyricum is lived to test group respectively
Bacteria preparation.Experimental period is 30 d.
Feeding and management
During test, daily 07:00、14:00 and 21:00 feeding, there to be a small amount of remaining material to be advisable in hopper, full period is certainly for feeding capacity
By searching for food and drinking water, epidemic prevention and feeding and management are carried out according to a conventional method.Daily 15:00 carries out diarrhoea statistics, observes simultaneously
The health status of piglet, record ill, extremely naughty piglet head number and its reason.
Index determining
Record each repetition piglet head number, diarrhoea daily and extremely wash in a pan situation, count a feed intake and diarrhea rate weekly, calculate day
All feed intakes；The off-test same day weighs, and counts full period feed intake, calculates full period feedstuff-meat ratio, piglet diarrhea rate and death rate.
Cecum microorganisms measure：Escherichia coli, Salmonella, lactobacilluss, the change of bifidobacteria.
Result of the test
The impact to Production Performance of Weaning Pigs and diarrhea rate for the Clostridium butyricum and its cecum microorganisms situation are shown in Table 5, table 6.
The impact to Production Performance of Weaning Pigs and diarrhea rate for table 5 Clostridium butyricum
The impact to ablactational baby pig cecum flora for table 6 Clostridium butyricum
Result shows, adds, in daily ration, the diarrhea rate that 0.025-0.2% Clostridium butyricum can significantly reduce ablactational baby pig, improves and produces
Performance, and significantly reduce escherichia coli and Salmonella quantity in caecum（Table 5 and 6）.
The impact to performance in layers, Egg Quality and cecum microorganisms for embodiment nine Clostridium butyricum
1 test method
1.1 material：Clostridium butyricum LXKJ-1（Every g of formulation contains clostridium butyricum active bacteria >=2.0 × 108cfu/g）
1.2 experimental animal：Red No. 1 laying hen in 46 week old capital
1.3 EXPERIMENTAL DESIGN：Test is using single-factor design.Choose 46 basically identical week old commercial generation laying hens of 960 body weight,
It is randomly divided into 5 groups, every group 6 repetitions, each repeats 32.Control group fed basal diet, 4 test group are respectively in basic day
In grain, Clostridium butyricum preparation addition is 125 g/t, 250 g/t, 500 g/t, 1000 g/t.14 days preliminary trial periods, the formal phase 56
My god.
Testing index
Egg laying performance：Average daily laying rate, average egg weight, daily output egg size, feed intake, feedstuff-egg ratio etc..
Egg quality：Hangh unit, shell thickness, eggshell strength.
Hangh unit：Hu=100lg（H-1.7W0.37+ 0.76), wherein H is dense albumen height/mm, and W is eggshell weight/g.
Cecum microorganisms measure：Escherichia coli, lactic acid bacteria, the change of bifidobacteria.
Result of the test
The impact to performance in layers for the 2.1 Clostridium butyricum LXKJ-1
Clostridium butyricum the results are shown in Table 7 to performance in layers impact.
The impact to performance in layers for table 7 Clostridium butyricum
The impact to laying hen Egg Quality for 2.2 Clostridium butyricum
Clostridium butyricum is shown in Table 8 to the impact of laying hen egg quality
The impact to laying hen Egg Quality for table 8 Clostridium butyricum
2. the impact to laying hen cecum microorganisms for 3 Clostridium butyricum
The impact to laying hen intestinal microorganism for the Clostridium butyricum is shown in Table 9
The impact to laying hen intestinal microorganism for table 9 Clostridium butyricum（Unit：lgcfu/g）
Result shows, adding 0.0125-0.1% Clostridium butyricum in daily ration can effectively improve performance in layers, improve eggshell product
Matter, has improvement trend to flora in intestinal simultaneously（Table 7,8,9）.
The growth-promoting effect to broiler for embodiment ten Clostridium butyricum
1 test method
1.1 material：Clostridium butyricum LXKJ-1（Every g of formulation contains clostridium butyricum active bacteria >=2.0 × 108cfu/g）
1.2 EXPERIMENTAL DESIGN：
Choose 1 age in days 10,000 plumage AA broiler to be tested, be divided into matched group and test group.Matched group feeds basal diet, test
Group Clostridium butyricum preparation addition in basal diet is 125 g/t, 250 g/t, 500 g/t, 1000 g/t, the test period
42 days.
Testing index
Growth performance measures：First day on-test, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weekend when, every group is selected 50 at random
Broiler is weighed, and averages, and calculates each group broiler weight.Record test early stage and the feed consumption rate in later stage, calculate broiler and put down
All daily gain, average daily gain and feedstuff-meat ratios.
Diarrhea rate and mortality rate：During record feeding, each group diarrhoea number of elements and dead number of elements, calculate diarrhea rate and death
Rate.
The mensure of Microflora in feces：Each group takes 1.0 g fresh excrement sample respectively, dilute using 10 times of gradient dilution methods
Release to 10-8, select continuous three dilution factors, be respectively coated on the differential medium flat board such as EMB, MRS, BBL, inoculum concentration
For 100 μ L/9cm flat boards, each dilution factor is 3 parallel, 37 DEG C of constant temperature culture 24-48 h.Predominantly detect in feces
Escherichia coli, lactic acid bacteria, the content of bacillus bifiduss.
Result of the test
The impact to meat chicken growth performance for 2.1 Clostridium butyricum
The impact to AA meat chicken growth performance for table 10 Clostridium butyricum
The impact to broiler cecum microorganisms for 2.1 Clostridium butyricum
The impact to laying hen intestinal microorganism for table 11 Clostridium butyricum（Unit：lgcfu/g）
Result shows, adds 0.0125%～0.1% Clostridium butyricum preparation and is remarkably improved broiler survival rate, promote life in daily ration
Long, improve weightening, reduce diarrhea rate simultaneously（Table 10）, increase the quantity of lactic acid bacteria and bacillus bifiduss in broiler caecum, reduce
Escherichia coli quantity（Table 11）.
The present invention from health pig intestinal separation screening one plant of Clostridium butyricum (Clostridium butyricum)LXKJ-
1, its activity is high, strong stress resistance, have found its growth suitable, the culture medium of breeding and condition of culture, fermentation gained culture simultaneously
Thing viable count is high, spore rate is high, and the medium component that this invention is used is simple, with low cost, is well suited for the scale of factory
Produce.Clostridium butyricum (Clostridium butyricum) LXKJ-1 is acidproof, alkaline-resisting, high temperature resistant, produces butanoic acid ability strong, to big
The animal pathogens such as enterobacteria, Salmonella, shigella, golden yellow Fructus Vitis viniferae bacillus, Listeria monocytogenes, bacillus perfringens
Diarrhoea all inhibited, that pig, chicken can be prevented to be caused by escherichia coli, Salmonella, bacillus perfringens etc., improves intestinal
Road colony balance, promotes pig, chicken growth, improves laying rate of laying hen and egg size, improve eggshell quality, reduce feedstuff-egg ratio.
<110>Hubei green snow bio tech ltd
<120>One plant of Clostridium butyricum and clostridium butyricum active bacteria preparation and application
<141>2016-10-28 <160>1 <210> 1 <211>The length of sequence<212>DNA
<213>Clostridium butyricum<400>Nucleotide sequence
agtgcggcagcttaccatgcagtcgagcgatgaagctccttcgggagtggattagcggcggacgggtgagtaa
cacgtgggtaacctgcctcatagaggggaatagcctttcgaaaggaagattaataccgcataagattgtagtaccgc
atggtacagcaattaaaggagtaatccgctatgagatggacccgcgtcgcattagctagttggtgaggtaacggctc
accaaggcgacgatgcgtagccgacctgagagggtgatcggccacattgggactgagacacggcccagactcctacg
ggaggcagcagtggggaatattgcacaatgggggaaaccctgatgcagcaacgccgcgtgagtgatgacggtcttcg
gattgtaaagctctgtctttagggacgataatgacggtacctaaggaggaagccacggctaactacgtgccagcagc
cgcggtaatacgtaggtggcaagcgttgtccggatttactgggcgtaaagggagcgtaggtggatatttaagtggga
tgtgaaatacccgggcttaacctgggtgctgcattccaaactggatatctagagtgcaggagaggaaaggagaattc
ctagtgtagcggtgaaatgcgtagagattaggaagaataccagtggcgaaggcgcctttctggactgtaactgacac
tgaggctcgaaagcgtggggagcaaacaggattagataccctggtagtccacgccgtaaacgatgaatactaggtgt
aggggttgtcatgacctctgtgccgccgctaacgcattaagtattccgcctggggagtacggtcgcaagattaaaac
tcaaaggaattgacgggggcccgcacaagcagcggagcatgtggtttaattcgaagcaacgcgaagaaccttaccta
gacttgacatctcctgaattactctgtaatggaggaagccacttcggtggcaggaagacaggtggtgcatggttgtc
gtcagctcgtgtcgtgagatgttgggttaagtcccgcaacgagcgcaacccttattgttagttgctaccatttagtt
gagcactctagcgagactgcccgggttaaccgggaggaaggtggggatgacgtcaaatcatcatgccccttatgtct
agggctacacacgtgctacaatggtcggtacaatgagatgcaacctcgcgagagtgagcaaaactataaaaccgatc
tcagttcggattgtaggctgaaactcgcctacatgaagctggagttgctagtaatcgcgaatcagaatgtcgcggtg
aatacgttcccgggccttgtacacaccgcccgtcacaccatgagagttggcaatacccaaagttcgtgagctaaccg
caaggaggcagcgacctaagtagtagagtt
agtgcggcagcttaccatgcagtcgagcgatgaagctccttcgggagtggattagcggcggacgggtgagtaa
cacgtgggtaacctgcctcatagaggggaatagcctttcgaaaggaagattaataccgcataagattgtagtaccgc
atggtacagcaattaaaggagtaatccgctatgagatggacccgcgtcgcattagctagttggtgaggtaacggctc
accaaggcgacgatgcgtagccgacctgagagggtgatcggccacattgggactgagacacggcccagactcctacg
ggaggcagcagtggggaatattgcacaatgggggaaaccctgatgcagcaacgccgcgtgagtgatgacggtcttcg
gattgtaaagctctgtctttagggacgataatgacggtacctaaggaggaagccacggctaactacgtgccagcagc
cgcggtaatacgtaggtggcaagcgttgtccggatttactgggcgtaaagggagcgtaggtggatatttaagtggga
tgtgaaatacccgggcttaacctgggtgctgcattccaaactggatatctagagtgcaggagaggaaaggagaattc
ctagtgtagcggtgaaatgcgtagagattaggaagaataccagtggcgaaggcgcctttctggactgtaactgacac
tgaggctcgaaagcgtggggagcaaacaggattagataccctggtagtccacgccgtaaacgatgaatactaggtgt
aggggttgtcatgacctctgtgccgccgctaacgcattaagtattccgcctggggagtacggtcgcaagattaaaac
tcaaaggaattgacgggggcccgcacaagcagcggagcatgtggtttaattcgaagcaacgcgaagaaccttaccta
gacttgacatctcctgaattactctgtaatggaggaagccacttcggtggcaggaagacaggtggtgcatggttgtc
gtcagctcgtgtcgtgagatgttgggttaagtcccgcaacgagcgcaacccttattgttagttgctaccatttagtt
gagcactctagcgagactgcccgggttaaccgggaggaaggtggggatgacgtcaaatcatcatgccccttatgtct
agggctacacacgtgctacaatggtcggtacaatgagatgcaacctcgcgagagtgagcaaaactataaaaccgatc
tcagttcggattgtaggctgaaactcgcctacatgaagctggagttgctagtaatcgcgaatcagaatgtcgcggtg
aatacgttcccgggccttgtacacaccgcccgtcacaccatgagagttggcaatacccaaagttcgtgagctaaccg
caaggaggcagcgacctaagtagtagagtt
Claims (9)
1. a kind of Clostridium butyricum it is characterised in that：Entitled LXKJ-1, specific name is：Clostridium butyricum LXKJ-1Clostrid
Ium butyricum LXKJ-1, deposit number is：CCTCC NO:M201613, preservation date：On March 24th, 2016, preservation
Address is：China, Wuhan, Wuhan University, depositary institution：China typical culture collection center.
2. by the clostridium butyricum active bacteria preparation of the Clostridium butyricum LXKJ-1 preparation described in claim 1.
3. as claimed in claim 2 a kind of clostridium butyricum active bacteria formulation preparation method it is characterised in that comprising the following steps：
1. by Clostridium butyricum (Clostridium butyricum) LXKJ-1 its be deposited in glycerol tube, freezing, by draw
Collimation method accesses slant medium, under anaerobic, 35～37 DEG C of culture 20～24h, wash lower spore with physiological saline solution and hang
Liquid, as original bacterium solution；
2. original bacterium solution is carried out amplification cultivation for strain, it comprises the following steps that：
The bacteria suspension of 1 volume is linked in the primary-seed medium of 20 volumes, in 1 L indigo plant lid reagent bottle, anaerobic condition
Under, 35～37 DEG C culture 8～12 h, as primary seed solution；
The primary seed solution of 1 volume is linked in the secondary seed medium of 10 volumes, in 20 L fermentation tanks, nitrogen environment
Under, 35～37 DEG C culture 8～12 h, as secondary seed solution；
Secondary seed solution is moved in the three grade fermemtation culture medium of 20 times of volumes, in 200 L fermentation tanks, under nitrogen environment, 35
～37 DEG C culture 20～24 h, that is, obtain Clostridium butyricum (Clostridium butyricum) LXK J-1 culture；
3. microorganism collection is carried out to culture using supercentrifugal process, the bacterium mud being collected by centrifugation；
4. press 1:1～5 defatted milk powder suspension of ratio interpolation 5～20%, sucrose, Lactose, trehalose, maltodextrin, Pyrusussuriensiss
One of alcohol, glycerol or more than one combination, as freeze drying protectant, prepare lyophilizing thalline using freeze-drying；
5. using one of glucose, starch, stone powder, zeolite powder, bean cake powder, maize cob meal, wheatfeed or more than one
Combination is diluted to mycopowder as adjuvant, as needed, is configured to the clostridium butyricum active bacteria preparation of different viable counts.
4. preparation method as claimed in claim 3 is it is characterised in that described slant medium is：Glucose 1.2%, L- half
Cystine 0.03%, sodium thioglycolate 0.03%, K2HPO40.2%, yeast extract 0.3%, soy peptone 0.5%, albumen
Peptone 1%, tryptone 1%, NaCl 0.3%, sodium alginate 0.5%, agar 2%, pH 6.5～7.0.
5. the preparation method as described in claim 3 or 4 it is characterised in that
Described primary-seed medium is：Glucose 5～30 g/L, L-Cysteine 0.1～5 g/L, sodium thioglycolate
0.1～5 g/L, K2HPO40.1～5 g/L, yeast extract 1～10 g/L, soy peptone 5～20 g/L, NaCl 1～
10 g/L, sodium alginate 1～10 g/L, pH 6.5～7.0；
Described secondary seed medium is：Peptone 10～40 g/L, soybean cake powder 1～5 g/L, glucose 10～30 g/L,
KNO30.5～2.0 g/L, K2HPO40.5～2.0 g/L, MgSO40.1～0.5 g/L, MnSO40.1～0.5 g/L, L-
Cysteine 0.1～1.0 g/L, sodium alginate 1.0～10 g/L, carbamide 1.0～5.0 g/L, CaCO31.0～10 g/
L, pH 6.5～7.0；
Described three grade fermemtation culture medium is：Semen Maydis powder 10～40 g/L, soybean cake powder 1～5 g/L, tryptone 10～40 g/L,
Glucose 10～40 g/L, NH4NO30.5～2.0 g/L, K2HPO4.5～2.0 g/L, MgSO40.1～0.5 g/L,
MnSO40.1～0.5 g/L, L-Cysteine 0.1～1.0 g/L, sodium alginate 1.0～10 g/L, carbamide 1.0～5.0
G/L, CaCO31.0～10 g/L, pH6.5～7.0；
Above all of culture medium is required for steam sterilization before use（121 DEG C, 30 min）, cool down stand-by.
6. a kind of Clostridium butyricum or Clostridium butyricum preparation as described in claim 2 as described in claim 1 is raised in preparation poultry
Application in material microbe additive.
7. application as claimed in claim 6 improves life it is characterised in that described clostridium butyricum active bacteria preparation is used for ablactational baby pig
Produce performance and reduce diarrhea rate.
8. application as claimed in claim 6 improves productivity it is characterised in that described clostridium butyricum active bacteria preparation is used for laying hen
Energy, Egg Quality, increase the quantity of lactic acid bacteria and bacillus bifiduss and reduction escherichia coli quantity in broiler caecum.
9. application as claimed in claim 6 improves broiler one-tenth it is characterised in that described clostridium butyricum active bacteria preparation is used for broiler
Motility rate reduces diarrhea rate, increases the quantity of lactic acid bacteria and bacillus bifiduss and reduction escherichia coli quantity in broiler caecum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610927003.9A CN106479924B (en) | 2016-10-31 | 2016-10-31 | The preparation and application of a kind of clostridium butyricum and clostridium butyricum active bacteria preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610927003.9A CN106479924B (en) | 2016-10-31 | 2016-10-31 | The preparation and application of a kind of clostridium butyricum and clostridium butyricum active bacteria preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106479924A true CN106479924A (en) | 2017-03-08 |
| CN106479924B CN106479924B (en) | 2018-06-12 |
Family
ID=58271161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610927003.9A Active CN106479924B (en) | 2016-10-31 | 2016-10-31 | The preparation and application of a kind of clostridium butyricum and clostridium butyricum active bacteria preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106479924B (en) |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107397042A (en) * | 2017-07-31 | 2017-11-28 | 广东省农业科学院动物卫生研究所 | A kind of composite type animal enteron aisle regulation preparation and preparation method thereof |
| CN107828688A (en) * | 2017-11-21 | 2018-03-23 | 湖北绿雪生物科技有限公司 | One plant of resistance to butyric acid, the clostridium butyricum of strong stress resistance and its application |
| CN107937305A (en) * | 2017-11-21 | 2018-04-20 | 湖北绿雪生物科技有限公司 | The strong clostridium butyricum microbial inoculum of one plant of resistance to butyric acid, resistance and its application |
| CN108165619A (en) * | 2017-12-29 | 2018-06-15 | 武汉轻工大学 | The feeding prebiotic bacterial screening method of anti-chicken C.perfringens infection |
| CN110151795A (en) * | 2019-05-14 | 2019-08-23 | 广东大泽农生物科技股份有限公司 | A kind of clostridium butyricum active bacteria preparation and its production technology |
| CN110218676A (en) * | 2019-06-13 | 2019-09-10 | 华南理工大学 | A kind of clostridium butyricum and its application |
| CN110819578A (en) * | 2019-12-18 | 2020-02-21 | 湖北华扬科技发展有限公司 | Strain preservation medium of clostridium butyricum and culture method thereof |
| CN110951640A (en) * | 2019-12-06 | 2020-04-03 | 山东蔚蓝生物科技有限公司 | Probiotic clostridium butyricum and application thereof |
| CN111500521A (en) * | 2020-06-11 | 2020-08-07 | 扬州大学 | Method for preparing clostridium butyricum preparation rich in selenium by using inorganic selenium and application of clostridium butyricum preparation |
| CN111728081A (en) * | 2020-04-03 | 2020-10-02 | 河南金百合生物科技股份有限公司 | Compound bacterium fermentation liquor for feed additive and preparation method thereof |
| CN112226389A (en) * | 2020-10-26 | 2021-01-15 | 新疆农业科学院微生物应用研究所（中国新疆-亚美尼亚生物工程研究开发中心） | Planting culture method of intestinal probiotic groups of Sanhuang young chickens and application of intestinal probiotic groups |
| CN112741210A (en) * | 2020-12-17 | 2021-05-04 | 湖北绿天地生物科技有限公司 | Biological preparation for improving animal organism immunity function and preparation method thereof |
| CN112760271A (en) * | 2021-03-02 | 2021-05-07 | 江西省科学院微生物研究所 | Process for producing clostridium butyricum through high-density fermentation under negative pressure condition and application |
| CN112980735A (en) * | 2021-03-29 | 2021-06-18 | 中粮营养健康研究院有限公司 | Clostridium butyricum, microbial inoculum, application of clostridium butyricum and microbial inoculum and preparation method of microbial inoculum |
| CN113133505A (en) * | 2021-06-01 | 2021-07-20 | 西南科技大学 | Preparation method of micro-ecological compound preparation containing clostridium butyricum |
| CN113699054A (en) * | 2020-05-20 | 2021-11-26 | 中粮生物科技股份有限公司 | Clostridium butyricum solid microbial inoculum and preparation method thereof |
| CN113999787A (en) * | 2021-08-30 | 2022-02-01 | 西安海吉焦生物科技研究院有限公司 | Clostridium butyricum, microbial inoculum, preparation method and application of microbial inoculum and feed |
| CN114107137A (en) * | 2021-12-24 | 2022-03-01 | 内蒙古科为博生物科技有限公司 | Clostridium butyricum and application and product thereof |
| CN114672446A (en) * | 2022-05-31 | 2022-06-28 | 广东海洋大学 | Preparation method and application of clostridium butyricum preparation |
| CN115704002A (en) * | 2021-08-11 | 2023-02-17 | 北京科为博生物科技有限公司 | Clostridium butyricum CC02001 and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103205375A (en) * | 2013-03-15 | 2013-07-17 | 厦门和美科盛生物技术有限公司 | Quality clostridium butyricum for breeding egg-laying poultry |
| CN103205373A (en) * | 2013-03-15 | 2013-07-17 | 厦门和美科盛生物技术有限公司 | Quality clostridium butyricum for breeding piglets |
| CN104277999A (en) * | 2014-09-15 | 2015-01-14 | 中国农业大学 | Novel multiple-effect Clostridium butyricum and application thereof in aspects of enhancing oxidation resistance of animals and improving meat quality |
-
2016
- 2016-10-31 CN CN201610927003.9A patent/CN106479924B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103205375A (en) * | 2013-03-15 | 2013-07-17 | 厦门和美科盛生物技术有限公司 | Quality clostridium butyricum for breeding egg-laying poultry |
| CN103205373A (en) * | 2013-03-15 | 2013-07-17 | 厦门和美科盛生物技术有限公司 | Quality clostridium butyricum for breeding piglets |
| CN104277999A (en) * | 2014-09-15 | 2015-01-14 | 中国农业大学 | Novel multiple-effect Clostridium butyricum and application thereof in aspects of enhancing oxidation resistance of animals and improving meat quality |
Cited By (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107397042A (en) * | 2017-07-31 | 2017-11-28 | 广东省农业科学院动物卫生研究所 | A kind of composite type animal enteron aisle regulation preparation and preparation method thereof |
| CN107828688B (en) * | 2017-11-21 | 2020-08-18 | 湖北绿雪生物科技有限公司 | Butyric acid-resistant clostridium butyricum with strong stress resistance and application thereof |
| CN107828688A (en) * | 2017-11-21 | 2018-03-23 | 湖北绿雪生物科技有限公司 | One plant of resistance to butyric acid, the clostridium butyricum of strong stress resistance and its application |
| CN107937305A (en) * | 2017-11-21 | 2018-04-20 | 湖北绿雪生物科技有限公司 | The strong clostridium butyricum microbial inoculum of one plant of resistance to butyric acid, resistance and its application |
| CN107937305B (en) * | 2017-11-21 | 2021-04-23 | 湖北绿雪生物科技有限公司 | Butyric acid-resistant strong-stress-resistant clostridium butyricum microbial inoculum and application thereof |
| CN108165619A (en) * | 2017-12-29 | 2018-06-15 | 武汉轻工大学 | The feeding prebiotic bacterial screening method of anti-chicken C.perfringens infection |
| CN110151795A (en) * | 2019-05-14 | 2019-08-23 | 广东大泽农生物科技股份有限公司 | A kind of clostridium butyricum active bacteria preparation and its production technology |
| CN110218676B (en) * | 2019-06-13 | 2021-03-30 | 华南理工大学 | Clostridium butyricum and application thereof |
| CN110218676A (en) * | 2019-06-13 | 2019-09-10 | 华南理工大学 | A kind of clostridium butyricum and its application |
| CN110951640A (en) * | 2019-12-06 | 2020-04-03 | 山东蔚蓝生物科技有限公司 | Probiotic clostridium butyricum and application thereof |
| CN110819578A (en) * | 2019-12-18 | 2020-02-21 | 湖北华扬科技发展有限公司 | Strain preservation medium of clostridium butyricum and culture method thereof |
| CN110819578B (en) * | 2019-12-18 | 2022-12-02 | 湖北华扬科技发展有限公司 | Strain preservation medium of clostridium butyricum and culture method thereof |
| CN111728081A (en) * | 2020-04-03 | 2020-10-02 | 河南金百合生物科技股份有限公司 | Compound bacterium fermentation liquor for feed additive and preparation method thereof |
| CN111728081B (en) * | 2020-04-03 | 2023-08-29 | 河南金百合生物科技股份有限公司 | Composite bacteria fermentation liquor for feed additive and preparation method thereof |
| CN113699054A (en) * | 2020-05-20 | 2021-11-26 | 中粮生物科技股份有限公司 | Clostridium butyricum solid microbial inoculum and preparation method thereof |
| CN111500521A (en) * | 2020-06-11 | 2020-08-07 | 扬州大学 | Method for preparing clostridium butyricum preparation rich in selenium by using inorganic selenium and application of clostridium butyricum preparation |
| CN112226389A (en) * | 2020-10-26 | 2021-01-15 | 新疆农业科学院微生物应用研究所（中国新疆-亚美尼亚生物工程研究开发中心） | Planting culture method of intestinal probiotic groups of Sanhuang young chickens and application of intestinal probiotic groups |
| CN112741210A (en) * | 2020-12-17 | 2021-05-04 | 湖北绿天地生物科技有限公司 | Biological preparation for improving animal organism immunity function and preparation method thereof |
| CN112760271A (en) * | 2021-03-02 | 2021-05-07 | 江西省科学院微生物研究所 | Process for producing clostridium butyricum through high-density fermentation under negative pressure condition and application |
| CN112980735B (en) * | 2021-03-29 | 2022-08-02 | 中粮营养健康研究院有限公司 | Clostridium butyricum, microbial inoculum, application of clostridium butyricum and microbial inoculum and preparation method of microbial inoculum |
| CN112980735A (en) * | 2021-03-29 | 2021-06-18 | 中粮营养健康研究院有限公司 | Clostridium butyricum, microbial inoculum, application of clostridium butyricum and microbial inoculum and preparation method of microbial inoculum |
| CN113133505A (en) * | 2021-06-01 | 2021-07-20 | 西南科技大学 | Preparation method of micro-ecological compound preparation containing clostridium butyricum |
| CN115704002A (en) * | 2021-08-11 | 2023-02-17 | 北京科为博生物科技有限公司 | Clostridium butyricum CC02001 and application thereof |
| CN115704002B (en) * | 2021-08-11 | 2024-04-26 | 北京科为博生物科技有限公司 | Clostridium butyricum CC02001 and application thereof |
| CN113999787A (en) * | 2021-08-30 | 2022-02-01 | 西安海吉焦生物科技研究院有限公司 | Clostridium butyricum, microbial inoculum, preparation method and application of microbial inoculum and feed |
| CN114107137A (en) * | 2021-12-24 | 2022-03-01 | 内蒙古科为博生物科技有限公司 | Clostridium butyricum and application and product thereof |
| CN114107137B (en) * | 2021-12-24 | 2024-02-06 | 内蒙古科为博生物科技有限公司 | Clostridium butyricum and application and product thereof |
| CN114672446A (en) * | 2022-05-31 | 2022-06-28 | 广东海洋大学 | Preparation method and application of clostridium butyricum preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106479924B (en) | 2018-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106479924B (en) | The preparation and application of a kind of clostridium butyricum and clostridium butyricum active bacteria preparation | |
| CN106011036B (en) | One plant of bacillus coagulans HEW-B379 and its application with prebiotic effect | |
| CN105132322B (en) | One lactobacillus plantarum and application thereof | |
| CN102876614B (en) | Bacillus licheniformis and application of bacillus licheniformis | |
| CN103981118B (en) | A kind of bacillus subtilis feed addictive and its preparation method and application | |
| CN105238722B (en) | The preparation method and application of one bacillus amyloliquefaciens bacterial strain and its bacterium powder preparation | |
| CN104651268B (en) | A kind of Lactobacillus plantarum and its application | |
| CN101671638B (en) | New strain of bifidobacterium and fermentative preparation method and application thereof | |
| CN105062933A (en) | Lactobacillus reuteri and application thereof | |
| CN102517238B (en) | Acid-producing bacillus cereus and application thereof | |
| CN102067941B (en) | Method for producing compound microbial preparation serving as fodder | |
| CN103525718B (en) | Bacillus cereus and probiotics powder thereof as well as preparation and application of probiotics powder | |
| CN106754579A (en) | A kind of bacillus coagulans and application thereof | |
| CN104293696A (en) | Enterococcus faecalis HEW-A131 and application thereof | |
| CN101971920B (en) | Porcine lactobacillus reuteri lyophilized preparation and preparation method thereof | |
| CN106906154A (en) | One lactobacillus plantarum strain and its feed addictive and feed | |
| CN102226157A (en) | Lactobacillus fermentum and application thereof | |
| CN102061272B (en) | Lactobacillus salivarius SIL1 and application thereof | |
| CN104673726A (en) | Porcine lactobacillus acidophilus freeze-drying preparation and application thereof | |
| CN107319129A (en) | A kind of preparation of fermented bean dregs rich in astaxanthin and feed | |
| CN109735471A (en) | One plant of Exiguobacterium sp and its application as probiotics on aquatic products | |
| CN105602865A (en) | Bacillus subtilis, fermentation method, powder and application | |
| CN108504697A (en) | A kind of clostridium butyricum fermentation process significantly improving butyric acid yield | |
| CN102391962A (en) | Enterococcus faecium preparation agent and manufacturing technology thereof | |
| CN102321552A (en) | Clostridium butyricum used for feeding, and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20231218 Address after: No. 5 Qigu Avenue, Changjiang Industrial Park, Economic Development Zone, Xianning City, Hubei Province, 437100 Patentee after: HUBEI LVXUE BIOLOGICAL INDUSTRY Co.,Ltd. Address before: 437100 No. 5 Qigu Avenue, High tech Industrial Park, Xianning City, Hubei Province, China Patentee before: HUBEI LYUXUE BIOTECHNOLOGY CO.,LTD. |
|
| TR01 | Transfer of patent right |